Healthcare Data Monetization Market worth $1.3 billion by 2031 - Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., Sept. 30, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Healthcare Data Monetization Market is projected to reach USD 1.3 billion by 2031 from USD 0.7 billion in 2026, at a CAGR of 14.5% during the forecast period.

Browse 350 market data Tables and 50 Figures spread through 400 Pages and in-depth TOC on "Healthcare Data Monetization Market - Global Forecast to 2031"

Healthcare Data Monetization Market Size & Forecast:

• Market Size Available for Years: 2026–2031
• 2026 Market Size: USD 0.7 billion
• 2031 Projected Market Size: USD 1.3 billion
• CAGR (2026–2031): 14.5%

Healthcare Data Monetization Market Trends & Insights:

• By type, the healthcare data monetization market has been segmented into direct and indirect data monetization. In 2025, the direct segment accounted for the largest market share driven by the growing demand among healthcare organizations to generate immediate revenue through the sale or licensing of data assets.
• By deployment, the cloud segment held the largest as well as fastest share during the forecast period. This growth is driven by the cloud's ability to offer unmatched scalability, flexibility, and cost-effectiveness.
• Based on data type, in 2025, the clinical data segment accounted for largest share of the healthcare data monetization market. The increasing adoption of electronic health records (EHRs), along with the growing use of AI and analytics to extract actionable insights, is driving the segment's growth.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=56622234

The healthcare data monetization market is driven by several key factors, including the rapid adoption of electronic health records (EHRs) that generate vast volumes of patient data, creating new opportunities for analysis and value extraction. Additionally, the rising use of external data sources and integration of large, complex healthcare datasets fuel market expansion. The urgent need to control escalating healthcare costs motivates providers and payers to leverage data for more efficient operations and better patient outcomes. Furthermore, advancements in AI, machine learning, and cloud computing enable sophisticated analytics and scalable data processing, facilitating innovative monetization strategies across the healthcare ecosystem.

Emerging technologies such as blockchain are enhancing data security and transparency, enabling secure and compliant healthcare data sharing across stakeholders. Advances in artificial intelligence (AI) and machine learning (ML) are driving deeper insights from complex datasets, facilitating personalized medicine and predictive analytics. The growing adoption of Internet of Medical Things (IoMT) devices generates real-time patient data, expanding monetization opportunities. For instance, in January 2026, Boehringer Ingelheim selected IQVIA's Data-as-a-Service (DaaS+) platform to support global commercial data harmonization across 59 countries. The initiative is designed to integrate commercial datasets into a unified cloud-based data foundation and enable advanced analytics and AI-powered decision-making. This is a strong example of the market moving beyond simple data licensing toward data-as-a-service and analytics-driven monetization.

The direct data monetization segment accounted for the largest share of the healthcare data monetization market.

The healthcare data monetization market is segmented into two types: direct and indirect data monetization. In 2025, the direct segment held the largest market share, driven by the increasing demand from healthcare organizations to generate immediate revenue through the sale or licensing of data assets. This direct data monetization segment is further divided into software and services. The software segment is projected to account for the largest share, fueled by the growing adoption of data analytics platforms, data integration tools, and secure data exchange solutions that facilitate real-time data monetization. These software solutions provide scalability, automation, and compliance features, making them essential for organizations seeking to manage and commercialize large volumes of health data efficiently.

The cloud segment is projected to grow at the highest CAGR in the healthcare data monetization market by deployment type.

The healthcare data monetization market includes on-premises and cloud models, with the cloud segment expected to grow the fastest. This growth is fueled by the scalability, cost-efficiency, and integration ease of cloud solutions, allowing healthcare organizations to manage large volumes of data effectively. Major tech companies are investing in cloud-based healthcare innovations. For instance, in March 2026, CVS Health announced a strategic partnership with Google Cloud to build Health100, an AI-native healthcare consumer platform. The platform uses Google Cloud's Gemini, Cloud Healthcare API, and BigQuery to connect data across pharmacies, providers, insurers, and digital health services, illustrating how cloud infrastructure is being used to aggregate and derive value from healthcare data.

Inquiry Before Buying: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=56622234

North America accounted for the largest share of the healthcare data monetization market in 2025.

In 2025, North America led the healthcare data monetization market, thanks to its advanced digital infrastructure, strong regulatory support, and an active investment landscape. The widespread adoption of electronic health records (EHRs), telehealth platforms, and connected devices has established a solid foundation for data generation and monetization. Regulatory initiatives like the 21st Century Cures Act in the US have encouraged data interoperability and improved patient access, promoting the broader use of health data for secondary purposes. Moreover, the presence of major technology and healthcare IT companies such as Oracle, IBM, Microsoft, and Salesforce has sped up the development and implementation of cloud-based, AI-enabled monetization solutions. The US is the major revenue contributor in North America, supported by large healthcare datasets, advanced data analytics capabilities, and growing investments in healthcare AI and cloud platforms.

Key Players

Leading players in the Healthcare Data Monetization companies include Oracle Corporation (US), Microsoft Corporation (US), Google (US), Salesforce, Inc. (US), SAS Institute Inc. (US), SAP SE (Germany), TIBCO Software Inc. (US), Sisense Inc. (US), Snowflake Inc. (US), QlikTech International AB (US), HealthVerity, Inc. (US), Accenture (Ireland), Availity, LLC (US), Domo, Inc. (US), Komodo Health, Inc. (US), ThoughtSpot Inc. (US), Datavant (US), Verato (US), Infor, Inc. (US), Virtusa (US), Infosys (India), Particle Health, Inc. (US), Innovaccer, Inc. (US), H1 (US), and Medoble Inc. (US).

Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=56622234

Healthcare Data Monetization Market - Investment & funding +Merger & Acquisition

Investment and Funding Context

The Healthcare Data Monetization market is witnessing increasing investment activity, primarily through strategic partnerships, acquisitions, expansion of real-world data (RWD) platforms, investments in data infrastructure, and development of AI-enabled healthcare analytics capabilities. In January 2026, IQVIA and Boehringer Ingelheim announced a strategic long-term collaboration focused on transforming Boehringer Ingelheim's commercial data foundation across 59 countries through IQVIA's Data-as-a-Service platform, supporting cloud-based data integration, advanced analytics, and AI applications. In February 2026, Thermo Fisher Scientific's PPD business announced a strategic collaboration with Datavant to expand real-world data interoperability and linkage capabilities, connecting clinical research with data from hundreds of RWD partners and tens of thousands of healthcare organizations in the U.S. In April 2026, Regeneron announced a strategic collaboration with TriNetX, including an investment of up to USD 200 million, to access de-identified electronic health records covering approximately 300 million individuals and combine them with Regeneron's genomic and proteomic data for research and product development. These developments indicate growing strategic investment in healthcare data platforms, RWD infrastructure, data interoperability, AI-enabled analytics, privacy-preserving data linkage, and commercial data access, with continued activity expected around data platform consolidation, healthcare data marketplaces, AI-ready datasets, and real-world evidence capabilities.

Revenue Shift Context

The Healthcare Data Monetization market is witnessing a gradual shift from traditional standalone healthcare data licensing toward integrated, AI-enabled, and data-as-a-service monetization models. The market is projected to increase from USD 0.7 billion in 2026 to USD 1.3 billion by 2031, at a CAGR of 14.5%. Traditional licensing of de-identified claims, EHR, pharmacy, laboratory, and other healthcare datasets remains an important revenue stream, particularly for pharmaceutical companies, biotechnology firms, payers, research organizations, and healthcare technology providers. However, demand is increasingly moving toward enriched and interconnected datasets that combine claims, EHR, clinical notes, genomic information, laboratory results, device data, and other real-world data sources. Healthcare data providers are also increasingly monetizing data through data-as-a-service, data marketplaces, subscription-based access, and insights-as-a-service models, allowing customers to access continuously refreshed datasets and analytical capabilities rather than purchasing static data files. The growing adoption of AI is further accelerating this transition, as pharmaceutical and healthcare organizations seek AI-ready datasets for drug discovery, clinical-trial optimization, patient cohort identification, real-world evidence generation, and personalized medicine. Strategic partnerships such as Inovalon and OMNY Health's 2026 collaboration, which combines claims data with EHR and clinical-note data, further demonstrate the increasing commercial value of linked and enriched healthcare datasets. These developments are supporting a broader shift toward data-as-an-asset and analytics-enabled revenue models, with increasing emphasis on interoperability, privacy-preserving data linkage, cloud infrastructure, responsible AI, and scalable healthcare data ecosystems.

Mergers and Acquisitions

Mergers and acquisitions in the Healthcare Data Monetization market are expected to remain active during 2025–2026, driven by consolidation among real-world data providers, healthcare data marketplaces, data interoperability platforms, analytics companies, and AI-enabled healthcare technology providers. Buyers are increasingly prioritizing de-identified EHR and claims datasets, real-world evidence capabilities, data marketplaces, patient-identity resolution, AI-ready data infrastructure, and data-linkage technologies. Strategic acquisitions and partnerships are also being used to expand data coverage, combine complementary datasets, strengthen commercial analytics capabilities, and create integrated platforms through which healthcare data can be licensed and monetized across pharmaceutical, biotechnology, payer, provider, and research applications.

HEALTHCARE DATA MONETIZATION MARKET: MERGERS AND ACQUISITIONS, JANUARY 2025–AUGUST 2026

Company Revenue Share Details

The top five players are estimated to account for approximately 45-55% of the Healthcare Data Monetization market, indicating a moderately fragmented competitive landscape characterized by large healthcare data providers, real-world data platforms, data marketplaces, analytics companies, and specialized data-linkage providers. The market includes Google, Microsoft, SAP, Oracle, and other healthcare data and analytics providers, with competitive positions supported by proprietary claims and EHR datasets, healthcare-provider relationships, data marketplaces, patient-identity resolution capabilities, cloud infrastructure, and advanced analytics platforms.

Browse Adjacent Market: Healthcare IT Market Research Reports &Consulting

See More Latest Healthcare IT Reports:

Healthcare IT Market by Solution [Clinical (EHR, PHM, PACs & VNA, Telehealth, RCM, CDSS, LIS), Nonclinical (Analytics, RCM, Pharmacy, Interoperability), Service (Claim, Billing, Supply)], End User (Hospital, ASC, Pharmacy, Payer) - Global Forecast to 2031

Healthcare Cloud Computing Market by Product (EHR, VNA, RIS, LIS, RCM, Telehealth), Deployment (Private, Public), Offering (Software), Pricing (Subs), Service Model (SaaS, IaaS, PaaS), End User (Hospital, ASC, Imaging Centers) - Global Forecast to 2031

About MarketsandMarkets™  

MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report.

MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe.

Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem.

The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing.

Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts.

MarketsandMarkets™ SalesPlay is an AI-driven Revenue Intelligence Co-Pilot designed to help revenue teams prioritize the right accounts, identify critical changes early, and surface opportunities ahead of demand, so pipeline builds naturally and deals close with greater consistency.

To find out more, visit www.MarketsandMarkets™.com or follow us on Twitter, LinkedIn and Facebook.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA: +1-888-600-6441
Email: [email protected]
Visit Our Website: https://www.marketsandmarkets.com/
Research Insight: https://www.marketsandmarkets.com/ResearchInsight/healthcare-data-monetization-market.asp
Content Source: https://www.marketsandmarkets.com/PressReleases/healthcare-data-monetization.asp

SOURCE MarketsandMarkets